Blog
Breast Cancer Treatment in India for Indonesian Patients: Diagnosis, Surgery & Targeted Therapy
Breast cancer is one of the most common cancers affecting women worldwide. For patients in Indonesia and their families, understanding the available diagnostic procedures, treatment approaches and specialist care options is an important part of making informed healthcare decisions.
According to the International Agency for Research on Cancer (IARC) GLOBOCAN 2022 estimates, Indonesia recorded approximately 66,271 new breast cancer cases, making breast cancer the most frequently diagnosed cancer among women in the country.
For patients exploring breast cancer treatment in India for Indonesian patients, India may be one of the destinations to consider when seeking specialist consultations, advanced diagnostic investigations and different cancer treatment approaches.
This guide explains breast cancer symptoms, diagnosis, surgery, chemotherapy, targeted therapy and the practical steps Indonesian patients can take when considering medical treatment in India.
Understanding Breast Cancer and Its Types
Breast cancer develops when abnormal cells in breast tissue begin growing uncontrollably. These cells can form a tumour and, in some cases, spread to nearby lymph nodes or other parts of the body.
Breast cancer can affect women of different ages, although the risk generally increases with age. In rare cases, men can also develop breast cancer.
Some commonly diagnosed types include:
1. Ductal Carcinoma In Situ (DCIS)
DCIS is a non-invasive form of breast cancer in which abnormal cells are found inside the milk ducts but have not spread into surrounding breast tissue.
It is generally considered an early-stage breast condition and requires appropriate medical evaluation and treatment planning.
2. Invasive Ductal Carcinoma (IDC)
Invasive ductal carcinoma is the most common type of invasive breast cancer.
It begins in the milk ducts and spreads into the surrounding breast tissue. Depending on the stage and tumour characteristics, treatment may involve surgery, radiation therapy, chemotherapy, hormone therapy or targeted therapy.
3. Invasive Lobular Carcinoma (ILC)
Invasive lobular carcinoma begins in the milk-producing glands called lobules.
It may have different growth patterns compared with invasive ductal carcinoma and can sometimes be more difficult to detect through routine physical examination.
4. HER2-Positive Breast Cancer
HER2-positive breast cancer occurs when cancer cells have increased levels of a protein called human epidermal growth factor receptor 2 (HER2).
This protein can encourage cancer cells to grow and divide.
Specific HER2-targeted medicines may be recommended for eligible patients, depending on the cancer stage and overall clinical condition.
5. Triple-Negative Breast Cancer
Triple-negative breast cancer is a subtype in which cancer cells test negative for:
- Estrogen receptors (ER).
- Progesterone receptors (PR).
- HER2 protein overexpression.
Because these cancers do not respond to conventional hormone therapy or HER2-targeted treatment, doctors may consider chemotherapy, immunotherapy in eligible cases and other treatment approaches.
Early Signs and Symptoms of Breast Cancer
Recognising unusual breast changes and seeking timely medical attention can help with early diagnosis.
Common symptoms may include:
- A new lump or thickening in the breast.
- Changes in breast size or shape.
- Unusual swelling in part of the breast.
- Changes in the appearance of breast skin.
- Nipple inversion or unusual discharge.
- Persistent pain in the breast or nipple area.
- Swelling or a lump in the underarm region.
- Redness or dimpling of breast skin.
Not every breast lump is cancerous. Benign conditions can also cause breast changes.
However, any new or persistent breast abnormality should be evaluated by a qualified healthcare professional rather than ignored.
Breast Cancer Diagnosis and Staging
Accurate diagnosis is essential before selecting a breast cancer treatment plan.
For Indonesian patients considering breast cancer treatment in India, previous medical reports can help specialists understand the diagnosis and determine whether additional investigations are required.
1. Clinical Breast Examination
A doctor examines the breasts and surrounding areas, including the underarm region, to identify unusual lumps, swelling or other changes.
The examination may also include a review of the patient’s medical and family history.
2. Mammography
Mammography uses low-dose X-rays to examine breast tissue.
It can help identify suspicious abnormalities, including small lumps and microcalcifications that may not be detectable through physical examination.
Doctors may recommend diagnostic mammography when a patient has symptoms or an abnormal screening result.
3. Breast Ultrasound
Breast ultrasound uses sound waves to produce images of breast tissue.
It can help distinguish fluid-filled cysts from solid masses and may also guide certain biopsy procedures.
4. Breast MRI
Magnetic Resonance Imaging (MRI) uses magnetic fields and radio waves to create detailed images of breast tissue.
It may be recommended in selected cases to evaluate the extent of disease, assess suspicious findings or assist with treatment planning.
5. Breast Biopsy and Histopathology
A biopsy involves collecting a tissue sample from a suspicious breast area.
The sample is examined under a microscope by a pathologist to determine whether cancer cells are present.
A histopathology report can provide important information about:
- Type of breast cancer.
- Tumour grade.
- Invasive or non-invasive characteristics.
- Other relevant tissue findings.
A biopsy is generally necessary to confirm a breast cancer diagnosis.
6. Breast Cancer Staging
Cancer staging helps doctors understand the extent of the disease.
Breast cancer is commonly classified into stages 0 to IV.
- Stage 0: Non-invasive cancer, such as DCIS.
- Stage I: Early invasive cancer, generally limited to the breast or involving only very limited nearby lymph node disease.
- Stage II: Cancer with greater tumour size or limited regional lymph node involvement.
- Stage III: More extensive local or regional disease.
- Stage IV: Cancer that has spread to distant organs or tissues.
The exact stage depends on tumour size, lymph node involvement, distant spread and other clinical and biological factors.
Important Breast Cancer Biomarker Tests: ER, PR and HER2
Breast cancer is not a single disease. Different tumours have different biological characteristics, and these differences can influence treatment decisions.
Biomarker testing is therefore an important part of breast cancer evaluation.
1. Estrogen Receptor (ER) Testing
ER testing identifies whether cancer cells have receptors that respond to estrogen.
Patients with hormone receptor-positive breast cancer may benefit from hormone therapy, depending on their diagnosis.
2. Progesterone Receptor (PR) Testing
PR testing identifies progesterone receptors in cancer cells.
The results help specialists understand the tumour’s hormone receptor status and guide treatment planning.
3. HER2 Testing
HER2 testing determines whether breast cancer cells show HER2 protein overexpression or gene amplification.
Common testing approaches include:
- Immunohistochemistry (IHC).
- Fluorescence In Situ Hybridisation (FISH), when additional assessment is required.
HER2-positive patients may be eligible for specific targeted therapies.
4. Ki-67 Testing
Ki-67 is a marker used to assess how actively cancer cells are multiplying.
It may provide additional information about tumour behaviour when interpreted alongside other pathological findings.
Together, these tests help doctors classify breast cancer into clinically relevant subtypes and develop an appropriate treatment strategy.
Breast Cancer Treatment Options in India
Breast cancer treatment depends on the tumour type, stage, biomarker results, overall health and patient preferences.
For Indonesian patients researching breast cancer treatment in India, the following treatment approaches may be relevant.
1. Breast Cancer Surgery
Surgery is an important treatment option for many patients with localised breast cancer.
The two commonly used surgical approaches are:
Lumpectomy (Breast-Conserving Surgery)
Lumpectomy involves removing the cancerous tumour along with a margin of surrounding healthy tissue while preserving most of the breast.
Radiation therapy is commonly recommended after breast-conserving surgery, depending on the patient’s diagnosis.
Mastectomy
Mastectomy involves removing the entire breast.
It may be recommended when the tumour is extensive, multiple areas of the breast are affected or breast-conserving surgery is not appropriate.
Some patients may also discuss breast reconstruction options with their surgical team.
Lymph Node Evaluation
Doctors may examine nearby lymph nodes to determine whether cancer has spread beyond the breast.
A sentinel lymph node biopsy or other lymph node procedure may be recommended depending on the clinical situation.
2. Chemotherapy
Chemotherapy uses medicines to destroy cancer cells or prevent them from multiplying.
It may be recommended:
- Before surgery to reduce tumour size.
- After surgery to lower the risk of recurrence.
- For certain aggressive breast cancer subtypes.
- For locally advanced or metastatic breast cancer.
The chemotherapy regimen and number of treatment cycles depend on the patient’s individual diagnosis.
3. Radiation Therapy
Radiation therapy uses high-energy radiation to destroy cancer cells in a specific area.
It may be recommended after lumpectomy and in selected cases after mastectomy.
The purpose is to reduce the risk of cancer returning in the treated region.
The radiation oncologist determines the treatment technique, dose and number of sessions.
4. Hormone Therapy
Hormone therapy may be recommended for hormone receptor-positive breast cancer.
These medicines work by reducing hormone production or blocking the effects of hormones that can encourage cancer cell growth.
Common examples include:
- Tamoxifen.
- Aromatase inhibitors such as anastrozole, letrozole and exemestane.
- Other hormone-based treatments in selected clinical situations.
Treatment duration varies according to the patient’s cancer type, stage and risk of recurrence.
5. HER2-Targeted Therapy
HER2-targeted therapy is designed to interfere with the HER2 protein pathway involved in the growth of certain breast cancers.
Some medicines used in eligible HER2-positive breast cancer patients include:
- Trastuzumab.
- Pertuzumab.
- Trastuzumab emtansine (T-DM1).
- Other HER2-directed medicines in selected situations.
These medicines may be used before or after surgery or in advanced disease, depending on the treatment plan.
6. Immunotherapy
Immunotherapy helps the immune system recognise and fight cancer cells.
Certain immunotherapy medicines may be considered for eligible patients with specific breast cancer subtypes, particularly selected cases of triple-negative breast cancer.
Biomarker testing, disease stage and treatment history may influence eligibility.
Not every breast cancer patient requires immunotherapy.
How Indonesian Patients Can Plan Breast Cancer Treatment in India
Travelling internationally for cancer treatment requires medical preparation and careful coordination.
Patients from Indonesia should consider the following steps before making travel arrangements.
Step 1: Organise Your Medical Reports
Prepare a complete set of medical documents, including:
- Biopsy and histopathology reports.
- ER, PR and HER2 test results.
- Mammography reports.
- Breast ultrasound reports.
- MRI, CT or PET-CT reports, if available.
- Previous surgery or treatment records.
- Recent blood investigation results.
- Current medication list.
Digital copies can help the receiving hospital conduct an initial medical record review.
Step 2: Request an Oncology Consultation
Contact the hospital to enquire about breast cancer specialist consultations.
Share your previous medical reports and ask whether the oncology team can conduct a preliminary review before travel.
The treating doctor may recommend additional investigations or an in-person examination before confirming a treatment plan.
Step 3: Understand Your Treatment Options
Before choosing a treatment destination, ask the hospital about:
- Available breast cancer specialists.
- Diagnostic and pathology facilities.
- Surgical treatment options.
- Chemotherapy and radiation services.
- HER2-targeted therapy availability.
- Estimated treatment duration.
- Potential side effects and risks.
- Follow-up arrangements.
Request a written treatment estimate wherever possible.
Step 4: Check Indian Medical Visa Requirements
Indonesian citizens planning to travel to India for medical treatment should verify the current Indian Medical Visa or applicable e-Medical Visa requirements.
Depending on eligibility and the visa route, the hospital may need to provide an invitation or treatment-related documentation.
Patients should check the latest requirements through the official Indian visa portal and the Indian Embassy or Consulate in Indonesia.
Step 5: Arrange Accommodation and Travel
Breast cancer treatment may involve several hospital visits, surgery, recovery and multiple treatment sessions.
Patients should plan for:
- Accommodation near the hospital.
- A family member or attendant, if required.
- Local transportation.
- Expected treatment duration.
- Financial and insurance arrangements.
- Follow-up consultations.
- Medical support after returning to Indonesia.
The travel plan should be finalised after the medical team has reviewed the case and discussed the expected treatment schedule.
What Is the Cost of Breast Cancer Treatment in India?
The cost of breast cancer treatment in India varies considerably depending on the patient’s diagnosis and recommended treatment plan.
There is no single price applicable to every breast cancer patient.
Important cost factors include:
- Diagnostic investigations and pathology tests.
- Breast surgery and hospitalisation.
- Chemotherapy medicines and treatment cycles.
- Radiation therapy techniques and sessions.
- HER2-targeted medicines.
- Immunotherapy, where indicated.
- Additional medical procedures.
- Follow-up consultations and investigations.
Patients from Indonesia should request a personalised estimate after sharing their medical reports.
It is also advisable to ask whether the estimate includes doctor’s fees, medicines, diagnostic tests, hospital charges and post-treatment follow-up.
Why Early Breast Cancer Detection Matters
Early diagnosis can improve the opportunity to treat breast cancer before it spreads to other parts of the body.
According to the World Health Organization, early detection and timely treatment play important roles in reducing breast cancer mortality.
Women should be aware of changes in their breasts and seek medical evaluation if they notice unusual symptoms.
Screening recommendations depend on age, personal risk factors, family history and national clinical guidelines.
Women with a strong family history or known inherited cancer-related genetic variants may need an individualised screening plan.
It is important to remember that breast cancer can also occur without obvious symptoms, which is why appropriate screening and medical evaluation matter.
Why Consider Galaxy Super Speciality for Cancer Care?
For Indonesian patients exploring breast cancer treatment in India, choosing a healthcare provider requires careful evaluation of medical expertise, diagnostic facilities, available treatment options and continuity of care.
Galaxy Super Speciality can be contacted to enquire about available oncology consultations, diagnostic services and the process for submitting previous medical reports for evaluation.
Before making a decision, patients should confirm:
- Whether the required breast cancer specialist is available.
- Whether relevant diagnostic tests can be performed.
- Which surgical and medical oncology services are offered.
- Whether targeted treatment is available when clinically indicated.
- What international patient assistance is provided.
- How follow-up care can be coordinated after returning to Indonesia.
The appropriate treatment plan should always be based on an individual medical assessment rather than a general recommendation.
Frequently Asked Questions (FAQs)
1. Can Indonesian patients receive breast cancer treatment in India?
Yes. Indonesian citizens may explore treatment at Indian hospitals, subject to specialist availability, hospital admission procedures and applicable medical visa requirements.
2. What is the best treatment for breast cancer?
There is no single best treatment for every patient. Treatment depends on the cancer stage, tumour subtype, hormone receptor status, HER2 status and overall health. Doctors may recommend surgery, chemotherapy, radiation, hormone therapy or targeted treatment.
3. What is HER2-positive breast cancer?
HER2-positive breast cancer is a subtype in which cancer cells have increased HER2 protein expression or gene amplification. Eligible patients may benefit from HER2-targeted medicines.
4. Is breast cancer surgery always necessary?
No. Surgery is commonly used for localised breast cancer, but treatment decisions depend on the disease stage, tumour characteristics and overall clinical condition. In certain advanced cases, systemic treatment may be prioritised.
5. What medical reports should Indonesian patients bring to India?
Patients should bring biopsy reports, histopathology findings, ER/PR/HER2 results, mammography, ultrasound or MRI reports, previous treatment records and recent blood investigations.
6. How long does breast cancer treatment take in India?
The duration depends on the treatment plan. Surgery may involve hospitalisation and recovery, while chemotherapy, radiation and targeted therapy can require repeated visits over several weeks or months.
7. Can breast cancer patients receive targeted therapy in India?
Targeted therapy may be available for eligible patients, depending on the cancer subtype, biomarker results, treatment history and the hospital’s available services.
8. How can I arrange a breast cancer consultation from Indonesia?
Contact the hospital’s appointment or international patient department, share your medical records and enquire about remote consultation availability, specialist review and the next steps for an in-person appointment.
Medical Disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis or treatment. Breast cancer treatment decisions must be made by qualified specialists after reviewing the patient’s individual medical condition.